Maat Pharma SA
PAR:MAAT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Maat Pharma SA
PAR:MAAT
|
FR |
|
OMV AG
LSE:0MKH
|
AT |
|
S
|
Salesforce Inc
SWB:FOO
|
US |
|
MGM Resorts International
NYSE:MGM
|
US |
|
Iberdrola SA
OTC:IBDSF
|
ES |
|
D
|
Da Ming International Holdings Ltd
F:DM7
|
CN |
|
Trade Desk Inc
NASDAQ:TTD
|
US |
|
F
|
Fresnillo PLC
DUS:FNL
|
MX |
|
B
|
Berkshire Hathaway Inc
SWB:BRYN
|
US |
|
Z
|
Zijin Mining Group Co Ltd
XMUN:FJZ
|
CN |
|
N
|
Nike Inc
XBER:NKE
|
US |
|
A
|
Alibaba Health Information Technology Ltd
F:TWYA
|
HK |
|
Quest Diagnostics Inc
NYSE:DGX
|
US |
|
COSCO Shipping Holdings Co Ltd
OTC:CICOY
|
CN |
|
R
|
Royal Gold Inc
LSE:0KXS
|
US |
|
D
|
DaVita Inc
XMUN:TRL
|
US |
|
Daiwa House Industry Co Ltd
OTC:DWAHF
|
JP |
|
Aryzta AG
SIX:ARYN
|
CH |
|
S
|
Singapore Post Ltd
XMUN:SGR
|
SG |
|
Cenergy Holdings SA
F:9CN
|
BE |
|
Papa John's International Inc
NASDAQ:PZZA
|
US |
|
D
|
Deutsche Post AG
SWB:DPWA
|
DE |
Bankruptcy Probability
Maat Pharma SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Maat Pharma SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
M
|
Maat Pharma SA
PAR:MAAT
|
51m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
429.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
153.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
122.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Maat Pharma SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Maat Pharma SA has total debt of 14.9m EUR. This includes both short-term (0 EUR) and long-term (14.9m EUR) debt.
You can find a full breakdown on its Balance Sheet.
